Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Syndecan-1 expression in different soft tissue tumours.

Z Orosz1, L Kopper

  • 1Department of Human and Experimental Tumour Pathology, National Institute of Oncology, H-1122 Budapest, Ráth György u. 7-9, Hungary. zso@oncol.hu

Anticancer Research
|April 13, 2001
PubMed
Summary

Syndecan-1 (CD138) expression in soft tissue tumors is not solely linked to epithelial differentiation. Its varied presence suggests complex roles beyond simple phenotypic association in these neoplasms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pleomorphic liposarcoma of bone: a rare primary malignant bone tumour.

Clinical sarcoma research·2018
Same author

Erratum to: Impact of repeated bouts of eccentric exercise on sarcolemma disruption in human skeletal muscle.

Physiology international·2017
Same author

Utility of VS38c in the diagnostic and prognostic assessment of osteosarcoma and other bone tumours/tumour-like lesions.

Clinical sarcoma research·2017
Same author

Granular cell tumour of the breast: case series and review of the literature.

European journal of gynaecological oncology·2011
Same author

Notch-regulation upon Dll4-stimulation of TGFb-induced apoptosis and gene expression in human B-cell non-Hodgkin lymphomas.

Scandinavian journal of immunology·2009
Same author

Impact of repeated bouts of eccentric exercise on sarcolemma disruption in human skeletal muscle.

Acta physiologica Hungarica·2009

Area of Science:

  • Oncology
  • Pathology
  • Biomarker Research

Background:

  • In vitro studies suggest syndecan-1 (CD138) expression correlates with tumor cell morphology (epithelioid or spindle).
  • Understanding syndecan-1's role in soft tissue tumors requires in vivo validation.

Purpose of the Study:

  • To investigate syndecan-1 (CD138) reactivity in a diverse panel of soft tissue tumors.
  • To correlate syndecan-1 expression patterns with tumor phenotype and differentiation.

Main Methods:

  • Analyzed syndecan-1 (CD138) reactivity in 57 soft tissue tumors.
  • Utilized immunohistochemical staining on paraffin-embedded sections with high-temperature unmasking.
  • Evaluated both the intensity and pattern of syndecan-1 staining.

Related Experiment Videos

Main Results:

  • Observed cell membrane positivity for syndecan-1 in epithelioid sarcomas and synovial sarcoma epithelial components.
  • Found intracytoplasmic syndecan-1 staining in GISTs, some epithelioid schwannomas, and fibromatosis.
  • Determined that pyogenic granuloma, Kaposi's sarcoma, fibrosarcoma, and dermatofibrosarcoma protuberans were negative for syndecan-1.

Conclusions:

  • Initial observations suggested syndecan-1 (CD138) cell membrane positivity indicated epithelial differentiation in soft tissue sarcomas.
  • Results indicate a non-specific expression pattern of syndecan-1 across various soft tissue tumors.
  • The heterogeneous expression of syndecan-1 suggests functions beyond simple phenotypic association, pointing to more complex roles in tumor biology.